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BMP is thought to induce hESC differentiation
toward multiple lineages including mesoderm and
trophoblast. The BMP-induced trophoblast pheno-
type is a long-standing paradox in stem cell biology.
Here we readdressed BMP function in hESCs and
mouse epiblast-derived cells. We found that BMP4
cooperates with FGF2 (via ERK) to induce mesoderm
and to inhibit endoderm differentiation. These condi-
tions induced cells with high levels of BRACHYURY
(BRA) that coexpressed CDX2. BRA was necessary
for and preceded CDX2 expression; both genes
were essential for expression not only of meso-
dermal genes but also of trophoblast-associated
genes. Maximal expression of the latter was seen in
the absence of FGF but these cells coexpressed
mesodermal genes and moreover they differed in
cell surface and epigenetic properties from placental
trophoblast. We conclude that BMP induces human
and mouse pluripotent stem cells primarily to form
mesoderm, rather than trophoblast, acting through
BRA and CDX2.
INTRODUCTION
The mesoderm lineage gives rise to the heart, blood, muscle,
kidney, and components of most other somatic tissues, plus
placental mesenchyme. Cell-based therapy and disease
modeling of any of these derivatives thus relies on a thorough
understanding of mesodermal origins. Embryonic and extraem-
bryonic mesoderm, together with definitive endoderm, emerge
during gastrulation via an epithelial-mesenchymal transition of
epiblast cells at the primitive streak. In the mouse, epiblast cells144 Cell Stem Cell 9, 144–155, August 5, 2011 ª2011 Elsevier Inc.poised to enter the distal primitive streak are subject to high
Nodal signaling and contribute to definitive endoderm. More
proximal epiblast cells are subject to high bone morphogenetic
protein (BMP) signaling and contribute extensively tomesoderm,
including extraembryonic mesoderm, which will form the umbil-
ical cord, the placental mesenchyme, and components of the
yolk sack and amnion (Lawson et al., 1991; Parameswaran and
Tam, 1995; Kwon et al., 2008; Burtscher and Lickert, 2009).
Human embryonic stem cells (hESCs) represent a promising
alternative system for understanding the mechanisms control-
ling early human development. Studies of hESCs have already
provided unequivocal evidence for an endoderm-inducing effect
of Activin (D’Amour et al., 2005) and have suggested that BMP
signaling is a key inducer of mesoderm (Schneider et al., 2003;
Goldman et al., 2009; Zhang et al., 2008; Yang et al., 2008).
However, BMP4 also induces the expression of genes associ-
ated with trophoblast (Xu et al., 2002) and extraembryonic endo-
derm (Vallier et al., 2009), and it cooperates with Activin to induce
differentiation of mesendoderm, the precursor of mesoderm and
endoderm (Vallier et al., 2009). The apparent capacity of hESCs
to differentiate into trophoblast and extraembryonic endoderm in
response to BMP4 is paradoxical, because they are derived by
culturing the inner cell mass (ICM) of expanded blastocysts. At
this stage, the inner cells (precursors of epiblast and primitive
endoderm) of mouse embryos no longer have the capacity for
differentiation into trophectoderm (Tarkowski et al., 2010) and
indeed mESCs only rarely colonize the trophectoderm in
chimeras (Beddington and Robertson, 1989). Moreover, mouse
EpiSCs, which are derived from pre-gastrula-stage late epiblast,
also express trophoblast-associated genes in response to BMP
(Brons et al., 2007; Tesar et al., 2007; Vallier et al., 2009). These
observations raise the question of whether the trophoblast-like
phenotype induced by BMP in hESCs and EpiSCs represents
an artifact related to their derivation and culture (Rossant,
2008; Silva and Smith, 2008) or alternatively models develop-
ment of the intact mammalian embryo by inducing expected
progeny of the late epiblast. The latter hypothesis would account
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BMP4 mutants have severe defects in embryonic and extraem-
bryonic mesoderm, but none in trophoblast (Winnier et al., 1995).
BMP4, alone or together with Activin, rapidly induces hESCs
to express the transcription factorBRACHYURY (BRA) and other
genes characteristic of mesendoderm, the common progenitor
of mesoderm and endoderm (Zhang et al., 2008; Yang et al.,
2008; Vallier et al., 2009). Progressive differentiation of these
cells is evident in expression of genes associated with definitive
endoderm, such as SOX17 and FOXA2, or with mid/distal and
proximal mesoderm, such as TBX6 or FLK1 (Murry and Keller,
2008). Growth factors responsible for mesoderm differentiation
of hESCs are not well understood, as BMP does not appear to
be the sole driver of mesoderm (Vallier et al., 2009). Fibroblast
growth factor (FGF) in particular has been used to promote
mesoderm specification and proliferation (Yang et al., 2008;
Yook et al., 2011). Understanding which growth factors distin-
guish between mesoderm, endoderm, and trophoblast differ-
entiation of hESCs is key to their ultimate use for cell-based
therapies and disease modeling.
A recent study used FGF2 to modulate the response of hESCs
to BMP4, finding that trophoblast-associated genes were
induced by BMP only in the absence of FGF (Yu et al., 2011).
Although complex trophoblast features, such as giant cell forma-
tion and hormone secretion, have been described in BMP-
treated hESCs, their trophoblast identity has principally been
based on their expression of such trophoblast-associated
genes, including CDX2, KRT7, HCGa, and GCM1 (Xu et al.,
2002; Zhang et al., 2008; Vallier et al., 2009; Wu et al., 2008).
However, these genes are not exclusively expressed in the
trophoblast (Roper and Hemberger, 2009). CDX2, for example,
not only affects trophoblast development but also plays an
essential role in mesoderm (Ralston and Rossant, 2008; Cha-
wengsaksophak et al., 2004; Savory et al., 2009). Indeed, the
embryonic expression pattern of Cdx2 and the postimplantation
phenotype of the knockout resemble those ofBra (Chawengsak-
sophak et al., 2004; Savory et al., 2009). Moreover, Elf5, a key
transcription factor in trophoblast lineage determination (Ng
et al., 2008), is not expressed in hESCs, in mEpiSCs or in tropho-
blast-like cells derived from hESCs (Hemberger et al., 2010).
These findings led us to re-examine whether the trophoblast-
associated genes induced by BMP are sufficient to identify the
resulting phenotype as trophoblast and to exclude epiblast-
derived lineages such as embryonic and extraembryonic meso-
derm. We studied the response to BMP4 in hESCs, in mEpiSCs,
and in explants of mouse late epiblast, using a combination of
gene expression analysis, shRNA knockdown, cell surface
analysis, and epigenetic characterization. These studies raised
doubts that the BMP-induced cells are trophoblast and sug-
gested instead that they are mesodermal in nature.
RESULTS
BRACHYURY and CDX2 Expression Are Induced
by Cooperative BMP and FGF Signaling
To understand how growth factor signaling regulates mesoderm
differentiation we grew hESCs and mEpiSCs in a chemically
defined medium (CDM) that has previously been used to deter-
mine the requirements for pluripotency and differentiation (Wilesand Johansson, 1999; Vallier et al., 2005). We used a combinato-
rial approach to determine the effects of 24 hr treatment with
ActivinA (100 ng/ml), BMP4 (10 ng/ml), and/or FGF2 (20 ng/ml),
(Figure 1A; Figures S1A and S1B, available online). As expected,
Activin treatment of hESCs induced the expression of SOX17
and FOXA2, reflecting endoderm differentiation. By contrast,
expression of BRA, TBX6, andCDX2were induced by BMP4, re-
flecting mesoderm and possibly trophoblast differentiation. This
response was most pronounced in the presence of FGF2 and
absence of Activin. The critical role of FGF in BMP-induced
differentiation was evident when the expression of BRA was
examined by immunoblotting (Figure 1B). Moreover, omission
of FGF or treatment with the FGF receptor inhibitor SU5402
(SU) effectively blocked BMP4-induced BRA expression (Fig-
ure S1C). These results indicate that FGF, whether provided
exogenously or obtained endogenously, was also important for
BMP-mediated BRA induction.
To further understand the role of FGF in BRA induction we
determined which of its effectors mediated this response. We
observed high levels of ERK1/ERK2 phosphorylation at 24 hr
of FGF treatment (Figure 1B) but did not observe increased
phosphorylation of JNK1/JNK2 or p38a (Figure S1D). Further-
more, inhibition of endogenous FGF signaling with SU5402
reduced phospho-ERK below the modest level seen in the
absence of added FGF (data not shown). In addition, the ERK
inhibitor UO126 (Uo) blocked BRA transcript and protein induc-
tion by BMP+FGF (Figure 1C). Hence, ERK1/2 activation corre-
lates with FGF signaling and is required for BMP-induced BRA
expression. While this study was underway, similar findings
were reported on the role of FGF2-ERK in hESCs (Yu et al., 2011).
Independently of FGF, BMP increased the levels of phosphor-
ylated SMAD1/5/8, the transcriptional effectors of canonical
BMP signaling (Figure 1B and data not shown). We further found
that FGF treatment bypassed the previously described require-
ment of Activin/Nodal signaling for BMP-induced BRA expres-
sion (Nostro et al., 2008) as cells treated with the Activin/Nodal
receptor inhibitor SB431542 (Sb) still upregulated BRA protein
production, provided that FGF was present (Figure 1B).
The responses to Activin, BMP, and FGFwere explored further
by simultaneous treatment with LY294002 (Ly), an inhibitor of the
PI3 kinase pathway, which facilitates differentiation of hESCs
(McLean et al., 2007) (Figure S1E). Induction of endoderm-asso-
ciated genes (SOX17 and FOXA2) by FGF2 + Ly + Activin (desig-
nated ‘‘FLyA’’) treatment did not require BMP signaling, as
demonstrated by use of the BMP inhibitor, Noggin (Figure 1D).
Conversely, induction of the mesodermal marker gene TBX6
and of CDX2 by FGF2 + Ly + BMP4 (designated ‘‘FLyB’’) treat-
ment did not require Activin/Nodal signaling, as it was not
blocked by Sb (Figure 1D). Immunostaining confirmed these
results and highlighted that BMP also induced CDX2 protein
expression (Figure 1E). Similar outcomes were observed when
mEpiSCs (Figure S1F and data not shown) or outgrowths of
late epiblast layers dissected from pre-gastrula stage mouse
embryos (Figure S1G) were treated with these conditions. In
summary, endoderm-associated gene expression (SOX17,
FOXA2) was induced by Activin + FGF, whereas mesoderm-
associated gene expression (TBX6) was induced by BMP + FGF
in hESCs, in EpiSCs, and in late epiblast outgrowths. The effect
of Activin/Nodal, BMP, and FGF on these pluripotent cellsCell Stem Cell 9, 144–155, August 5, 2011 ª2011 Elsevier Inc. 145
Figure 1. BMP and FGF Cooperate to Induce BRA and CDX2
(A) qPCR analysis of hESCs grown as indicated. Colored bars represent the absence (blue) or presence (red) of BMP4. *p% 0.05; +p% 0.01; t test.
(B) Immunoblots of hESCs grown as indicated, where ‘‘Sb’’ refers to inhibition of Activin/Nodal signaling by SB431542, ‘‘-’’ is no Activin addition and ‘‘10’’ or ‘‘100’’
is the ng/ml Activin.
(C) qPCR analysis (i) and immunoblots (ii) of hESCs grown as indicated; ‘‘Uo’’ is ERK inhibitor UO126. In (i) *p% 0.05; +p% 0.01; t test; comparisons done to day
0 are indicated in black, and comparisons between the two indicated treatments are in red.
(D) qPCR analysis of hESCs grown as indicated; pluripotency conditions (day 0, D0), CDM alone, DMSO control, FLyB, or FLyA plus other factors as indicated
below each histogram (Nog, Noggin at 200 ng/ml; B, BMP at 10, 50, or 100 ng/ml; Sb, SB431542 at 10 mM; A, Activin at 10, 50, or 100 ng/ml). *p% 0.05; +p% 0.01;
t test.
(E) Representative fluorescent images of hESCs grown as indicated. Samples were immunostained for BRA, FOXA2, and CDX2. See also Figure S1.
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mouse embryos.
Distinct BRAhigh/CDX2+ and BRAlow/SOX17+
Populations Emerge from FLyB and FLyA Treatments
The reciprocal effects of Activin/Nodal and BMP signaling as
inducers of endoderm and mesoderm gene expression, respec-
tively, prompted a deeper examination of the nature of cells in
such conditions. As BRA mRNA peaked between 24 hr and
36 hr of either FLyA or FLyB treatment (Figure S2A), protein anal-146 Cell Stem Cell 9, 144–155, August 5, 2011 ª2011 Elsevier Inc.yses were performed at 36 hr. Flow cytometry analysis showed
that FLyA and FLyB treatments each generated 65%–90%
BRA expressing cells (Figures 2A and 2C; Figure S2B). However,
FLyB induced higher levels of BRA expression than FLyA (Fig-
ure 2A; Figure S2C). Moreover, in FLyB-treated hESCs, BRA
colocalized with CDX2, while in FLyA-treated hESCs, BRA colo-
calized with SOX17 (Figure 2A); this result was confirmed in
a second hESC line, HuES9 (Figure S2B). Thus, FLyA and
FLyB treatments, respectively, evoked two distinct phenotypes:
a BRAlow population, a majority of which (55% of the total
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population, many of which (45% of the total BRA-positive cells)
colocalized with CDX2+ (Figure 2A).
As levels of Bra expression in the mouse primitive streak have
been shown to influence cell recruitment and their phenotype
(Wilson and Beddington, 1997), we hypothesized that 36 hr
FLyA and FLyB treatments would induce broadly different
gene expression profiles. The heat map of predominantly up-
or downregulated genes confirmed that characteristic endo-
derm-associated genes (D’Amour et al., 2005) were upregulated
in FLyA and downregulated or absent in FLyB (Figure 2B).
Conversely, of numerous genes that were upregulated in FLyB
and downregulated or absent in FLyA, many were explicitly
mesodermal (e.g., ISL1, TBX6, LMO2) and some were tropho-
blast associated (e.g., HAND1, CDX2). Other genes were upre-
gulated in both conditions (e.g., BRA,MIXL1,MESP1, EOMES),
suggesting that they distinguish a mesendodermal population.
To extend these results, we investigated the protein expression
of HAND1, MESP1, and FOXA2 in FLyB and FLyA conditions
(Figure 2C; Figures S2D and S2E). Flow cytometry analysis
showed that, as suggested by the transcriptional profiles,
HAND1 and FOXA2 expression were only observed in BMP or
in Activin, respectively. As before, both treatments induced
a high proportion of BRA-expressing cells (approximately
80%–90%). HAND1 expression in response to FLyB mainly co-
localized with BRA in BRAhigh cells and also colocalized with
CDX2 (65% of HAND1+ cells). By contrast, FOXA2 expression
in response to FLyA mainly colocalized with BRA in BRAlow cells
and with SOX17 (65% of FOXA2+ cells). As expected from their
transcriptional profiles, both FLyB- and FLyA-treated hESCs ex-
pressed MESP1, which colocalized with BRA in both BRAhigh
and BRAlow cells. Taken together, these results confirmed that
mesoderm and endoderm emerged as two distinct populations
in response to treatment with BMP + FGF or Activin + FGF,
respectively.
The above observations also raised the possibility that tropho-
blast-associated genes such as CDX2 and HAND1, which are
coexpressed with BRA in BRAhigh cells, are expressed in, and
play a role in, mesoderm. To test this hypothesis we subjected
36 hr FLyB-treated cells to a longer mesoderm differentiation
protocol by exposing them to an additional 3.5 days ofBMP+FGF.
CDX2 expression was induced by this protocol not only in
hESCs (Figure 2D) but also in mEpiSCs (Figure S2F) and in
epiblast explants (Figure S2G). Since trophoblast gene expres-
sion has been reported in hESCs treated with BMP alone (Xu
et al., 2002; Yu et al., 2011), we also examined the influence of
FGF on expression of CDX2 and other genes induced by BMP.
Omission of FGF2 (Figure 2E) revealed its critical role in
promoting the expression of ISL1, NKX2.5, CD31, and LMO2 in
BMP-treated cells. Each of these is integral to development of
one or more embryonic mesoderm subtypes. High expression
of CDX2 also depended on FGF signaling and decreased in its
absence. In contrast, expression of other trophoblast-associ-
ated genes (GCM1, HCGa, KRT7) was highest in the absence
of FGF (Figure 2E), as recently also found by Yu et al. (2011).
However, FLK1, VCAM1, and TBX4, three BMP-induced genes
with essential roles in both embryonic and extraembryonic
mesoderm (Yamaguchi et al., 1993; Gurtner et al., 1995; Naiche
and Papaioannou, 2003), were also highly expressed in theabsence of FGF (Figure 2F). Collectively, the patterns of gene
expression in response to BMP either with or without FGF
suggest that these two conditions induce distinct molecular
phenotypes, but that both are mesodermal in nature.
Expression of Both Embryonic and Extraembryonic
Lineage-Associated Genes in BMP-Treated hESCs
Depends on a BRA-Driven Gene Regulatory Network
To test the hypothesis that trophectoderm-associated genes are
actually expressed in cells of the mesodermal lineage, we deter-
mined their dependence on a BRA-centered regulatory network.
This approach was based on observations that there are no
trophoblast phenotypes in homozygous Bra mouse mutants
(Beddington et al., 1992). We thus evaluated the effect of BMP
treatment on hESCs in which BRA was stably knocked down
using transcript-specific short-hairpin RNAs (sh-BRA). As antic-
ipated from its role in mesoderm development in mouse and
other species, knockdown of BRA in hESCs significantly
reduced transcription of key mesoderm genes (FLK1, ISL1,
and CD31) (Figure S3A). Interestingly, BRA knockdown also
nearly completely eliminated CDX2 expression in FLyB treated
cells (Figures 3A and 3B), revealing that CDX2 induction is
dependent on BRA in these conditions. Consistent with this,
hESCs treated with FLyB expressed BRA before they expressed
CDX2, which accumulated as protein almost exclusively in
BRA-expressing cells (Figure S3B). Low levels ofCDX2 induction
were nevertheless detected in wild-type hESCs treated with Sb
or SU (Figure S3C), suggesting that CDX2 is less dependent on
BRA under such conditions. To determine whether BRA was
required for expression of other BMP-induced extraembryonic
genes, the sh-BRA knockdown lines were treated for 5 days
with BMP + Sb, which induces the highest levels of tropho-
blast-associated genes (Wu et al., 2008 and Figure S3D) and
the lowest levels of mesoderm-associated genes (Figure 1B;
Figures S3C and S3E). This revealed that even in BSb conditions
the BRA knockdown lines were defective in CDX2 as well as in
the expression of both trophoblast-associated (HCGa, GCM1)
and mesoderm-associated genes (FLK1, TBX4, ISL1, LMO2,
and CD31) (Figure 3C; Figure S3F).
We then similarly evaluated the role of CDX2. Notably,
although BRA knockdown eliminated CDX2 expression, CDX2
knockdown did not reciprocally significantly affect BRA expres-
sion (Figures 3D and 3E). However, when sh-CDX2 hESCs were
differentiated toward proximal- or mid/distal-streak mesoderm
for 5 days, they showed significantly reduced expression of
other mesoderm genes, including markers of haemangioblast
(FLK1, CD31, and LMO2), heart (FLK1, MESP2, NKX2.5, and
ISL1), and paraxial mesoderm (MESP2 and TBX6) (Figure 3F;
Figure S3G). Interestingly, the CDX2 knockdown also reduced
expression of the trophoblast-associated genes HCGa, GCM1,
and KRT7 (Figure S3H). Likewise, CDX2 knockdown lines
treated for 5 days with BMP + Sb expressed significantly
reduced levels of TBX4, VCAM1, ISL1, CD31, and LMO2 (Fig-
ure 3G; Figure S3H). Thus, CDX2 knockdown affected not only
expression of trophoblast-associated genes but also expression
of a large panel of mesoderm genes both in the presence and the
absence of exogenous FGF signaling.
In summary, theBRA-driven gene regulatory network in hESCs
includes CDX2, and together these are necessary for expressionCell Stem Cell 9, 144–155, August 5, 2011 ª2011 Elsevier Inc. 147
Figure 2. Distinct BRAhigh/CDX2+ and BRAlow/SOX17+ Populations Emerge from FLyA and FLyB Treatments
(A) Flow cytometry histograms of hESCs grown as indicated. Circles represent subpopulations of BRAhigh and BRAlow cells, which colocalize with CDX2 or
SOX17, respectively.
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Figure 3. Expression of Both Embryonic and Extraembryonic Lineage-Associated Genes in BMP-Treated hESCs Depends on a BRA-Driven
Gene Regulatory Network
(A) qPCR analysis of sh-BRA knockdown (BRA KD) hESC lines and a scrambled control line (Scramble) grown as indicated. *p% 0.05; +p% 0.01; t test.
(B) Representative fluorescent images of BRA KD and control hESCs grown as indicated. Samples were immunostained for CDX2, BRA, and DAPI.
(C) qPCR analysis of sh-BRA KD and control hESCs grown as indicated to induce expression of extraembryonic genes. *p% 0.05; +p% 0.01; t test.
(D) qPCR analysis of sh-CDX2 knockdown (CDX2 KD) hESC lines and a control line grown as indicated. *p% 0.05; +p% 0.01; t test.
(E) Representative fluorescent images of CDX2 KD and control hESCs grown as indicated. Samples were immunostained for CDX2, BRA, and DAPI.
(F) qPCR analysis of CDX2 KD and control hESCs differentiated as indicated. *p% 0.05; +p% 0.01; t test.
(G) qPCR analysis of CDX2 KD and control hESCs grown as indicated. *p% 0.05; +p% 0.01; t test. See also Figure S3.
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gene sets.Characteristics of BMP-Treated hESCs Distinguish
Them from Placental Trophoblast
To resolve the identity of these cells, we examined BMP-treated
hESCs further. We focused on well-characterized epigenetic
properties of trophoblast cells, namely on the epigenetic status
of their ELF5 promoter (Ng et al., 2008; Hemberger et al., 2010)
and on the characteristic repertoire of human leukocyte antigen(B) Microarray gene expression heat map of undifferentiated (day 0, D0) vers
fold-changes.
(C) Flow cytometry histograms showing BRA coexpression with HAND1, MESP1
(Di) qPCR analysis of hESCs induced to differentiate toward proximal streak me
(Dii) Representative fluorescent image of D5 hESCs grown as indicated. Sample
(E) qPCR analysis of hESCs differentiated as indicated. *p% 0.05; +p% 0.01; t
(F) qPCR analysis of hESCs differentiated as indicated. See also Figure S2.(HLA) class I molecules expressed by human trophoblast cells
in vivo (Apps et al., 2009).
In the mouse and human trophoblast lineages, ELF5 is hypo-
methylated (z9%) and highly expressed, but it is hypermethy-
lated and silenced in mEpiSCs and hESCs (Ng et al., 2008; Hem-
berger et al., 2010). In the absence of FGF, BMP-treated cells
expressed some ELF5, albeit at low levels (with a cycle threshold
[CT] of 32), and ELF5-positive cells comprised only a small
fraction of cells (Figure 4A). Consistent with this, the ELF5
promoter was highly methylated in BMP-treated hESCs and
the critical CpG dinucleotides surrounding the transcriptionalus differentiated hESCs grown as indicated. Heat-map colors indicate log2
, or FOXA2 in hESCs grown as indicated.
soderm (D5) and untreated controls (pluripotency conditions - D0).
s were immunostained for CDX2.
test. Comparisons were done between the two indicated treatments.
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Figure 4. Characteristics of BMP-Treated
hESCs Distinguish Them from Placental
Trophoblast
(Ai) qPCR analysis of ELF5 expression in hESCs
grown as indicated.
(Aii) Representative fluorescent images of hESCs
grown as indicated. Samples were immuno-
stained for ELF5.
(B) Bisulphite sequencing analysis of the ELF5
promoter region inhESCsgrownas indicated.Filled
circles indicate methylated cytosine residues. Top
row: hypomethylation status in placental tropho-
blast. Distance from ATG is shown in base pairs.
(C) Table of HLA class I gene expression in
placental (in vivo) trophoblast (Apps et al., 2009)
and hESCs grown in pluripotency (day 0, D0) or in
differentiating conditions as indicated. Legend: -,
no expression (0%–4%); +/, 5%–30%; +, 31%–
50%; ++, 51%–70%; +++, 71%–100% of the
cells, as determined by flow cytometry.
(D) Representative images of placental serial
sections stained for HLA-G or the 1B10-fibroblast
antigen (1B10-Fib). Arrows indicateHLA-G-positive
extravillous trophoblast cells; arrowheads indicate
1B10-fibroblast-negative villous trophoblast.
(E) Flow cytometry histograms showing class I
HLA expression (detected by W6/32 antibody)
and the epitope detected by 1B10-fibroblast
antibody (1B10-Fib) in hESCs grown in pluri-
potency conditions (hESCs) or in differentiating
conditions as indicated. See also Figure S4.
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samples. Slightly lower methylation was seen with BMP + Sb
treatment (Figure 4B); this correlated with slightly raised ELF5
transcript levels, which were still much lower than in placental
trophoblast (Hemberger et al., 2010). Nevertheless, the majority
of CpGs remained methylated across the ELF5 promoter.150 Cell Stem Cell 9, 144–155, August 5, 2011 ª2011 Elsevier Inc.To further evaluate the cellular identity
of BMP-treated hESCs, we assessed
the repertoire of HLA class I expression
in two independent hESC lines. The two
main placental trophoblast subpopula-
tions in vivo are distinguished by their
expression of HLA class I molecules.
Villous trophoblast does not express any
HLA class I molecules while the extravil-
lous population has a unique pattern of
expression characterized by the classical
HLA-C and nonclassical HLA-E and
HLA-G molecules. Highly polymorphic
classical HLA-A and HLA-B molecules
are not expressed in either trophoblast
population (Apps et al., 2009). We found
that 75%–95% of BMP-treated hESCs
expressed class I HLA molecules, as de-
tected by the W6/32 antibody, which
recognizes this entire class. However,
while BMP-treated hESCs (with or with-
out FGF or Sb) expressed HLA-A and
HLA-B molecules, these cells lackeddetectable surface expression of HLA-G or HLA-C (Figure 4C;
Figures S4A and S4B). These results suggest that if any tropho-
blast cells arose from BMP treatment of hESCs, they were a
minor population of class I HLA negative cells, which by analogy
with in vivo tissues could only be villous trophoblast. We then
triple-stained BMP-treated hESCs for class I HLA, for EGFR (a
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and for 1B10-antigen (a marker of villous syncytiotrophoblast;
Figure 4D) (Figure 4E). There was no detectable expression of
EGFR in the various BMP-treated cultures (data not shown).
However, the vast majority (80%–90%) of the BMP-treated
hESCs expressed the 1B10-antigen, which is also typically ex-
pressed in adult fibroblast tissues of mesodermal origin (Singer
et al., 1989). The 1B10 antigen was almost exclusively detected
in cells coexpressing HLA class I molecules as detected by
W6/32 (Figure 4E). Thus, these data exclude the possibility that
an authentic trophoblast population emerges after BMP treat-
ment of hESCs, even in the conditions most favorable to the
appearance of such a phenotype.
Cells Expressing HCGa, GCM1, and KRT7 Represent
a Subpopulation of Mesoderm Cells
As BMP-induced cells do not fulfill essential criteria of the
trophoblast lineage, it is important to establish their correct
lineage identity. All in vivo placental trophoblast subpopulations
express KRT7, so we used it as a marker for trophoblast-like
cells that resulted from BMP treatment of hESCs. Neither H9
nor HuES9 hESC lines expressed KRT7 when grown in CDM
supplemented with Activin + FGF, which maintain pluripotency
in chemically defined conditions (Figure S5A and S5B). We
then sought to determine whether KRT7+ cells coexpressed any
mesoderm lineage-specific genes when cultured in BMP + Sb,
the condition that maximally induced KRT7. In each case, there
was a small fraction (4%–8%) of BMP-treated cells that ex-
pressed KRT7, and virtually all of these coexpressed meso-
derm-associated genes. Q-PCR analysis of KRT7+ sorted cells
revealed expression of FLK1, VCAM1, and TBX4 and other
mesoderm-associated genes (CD31 and LMO2) (Figure 5A; Fig-
ure S5C). KRT7+ cells also robustly coexpressed GCM1 and
HCGa and expressed ELF5 at lower levels (Figure 5A).We further
verified coexpression of KRT7 protein with ISL1, FLK1, and
VCAM1 using immunostaining and flow cytometry and we
made similar observations in the HuES-9 hESC line (Figures 5B
and 5C; Figures S5D and S5E). In sum, the coexpression of
KRT7 with multiple mesoderm-associated genes indicates that
BMP promoted differentiation to a mesodermal phenotype in
which a subpopulation of cells expressed genes commonly
regarded as markers of the trophoblast lineage, but these cells
did not fulfill other criteria of a bona fide trophoblast identity.
We also considered whether the expression of trophoblast-
associated genes in response to BMP treatment could be a
consequence of derivation and prolonged culture. When ex-
plants of mouse late epiblast were treated directly with BMP4,
they expressed high levels of Cdx2 and increased expression
of Vcam1, Flk1, and Tbx4; they also had increased expression
of Krt7 and Gcm1 (Figure 5D; Figure S1F). Moreover, explant
cultures of human placental mesenchyme that had been purified
by cell sorting also expressed KRT7, GCM1, and HCGa (Fig-
ure 5E). Thus, in both cases expression of trophoblast-associ-
ated genes occurred in the absence of stem cell derivation or
prolonged culture.
Finally, we considered whether the multinucleated mor-
phology of sporadic cells in BMP-treated hESCs (Figures S5F
and S5G) represented a syncytiotrophoblast-like population
abnormally devoid of EGFR expression. Interestingly, suchmultinucleated cells resembled those appearing after several
days (observed from passage 1) in primary cultures of human
placental extraembryonic mesenchyme purified by cell sorting
(Figure S5H). As syncytiotrophoblast cells are KRT7-positive,
1B10-positive, and HLA class I-negative, we asked whether
KRT7 expression colocalized with the syncytiotrophoblast
marker 1B10 or with HLA class I molecules (detected by
W6/32 antibody) or the specific HLA-A and HLA-B molecules
(detected by Tu155 antibody). The multinucleated cells stained
positive for KRT7 (Figure 5F). Furthermore, KRT7+ cells cos-
tained positive for each of these (1B10 and HLA class 1-specific)
antibodies (Figure 5G). Despite staining positive for the 1B10
marker, the positive signal for HLA class I molecules thus
excludes the possibility that these KRT7-expressing cells are
syncytiotrophoblast. Instead, their phenotype suggests a meso-
dermal identity, possibly corresponding to extraembryonic
placental mesenchyme.
DISCUSSION
Our results reveal how BMP4 and FGF2 (via ERK) cooperate to
drive efficient hESC differentiation into early mesodermal cells,
which characteristically express high levels of BRA. These cells
coexpress CDX2, a gene commonly thought to be trophoblast
specific but whose coexpression in cells with BRA suggests
instead an either embryonic or extraembryonic mesodermal
identity, consistent with patterns of Cdx2 expression observed
in the E7.5 mouse embryo (Beck et al., 1995). We further find
that Activin/Nodal and FGF2 signaling promotes endoderm
differentiation, characterized by lower levels of BRA expression,
which often colocalizes with SOX17 and FOXA2 (genes regarded
asmarkers of definitive endoderm and shown here to be induced
in early response to FLyA). Mouse EpiSCs and epiblast explants
respond similarly to these conditions. Overall, these responses
resemble those of the intact mouse embryo, highlighting the
likely relevance of the mechanisms underlying in vitro cell fate
decisions to in vivo embryonic development and their evolu-
tionary conservation among mammals.
Using sh-RNAs to perturb BRA and CDX2 function, we found
that they both regulatemesodermal gene expression, concurring
with previous studies in themouse (Beddington et al., 1992; Cha-
wengsaksophak et al., 2004; Savory et al., 2009). Intriguingly,
BRA regulates CDX2 expression in hESCs, but CDX2 did not
regulate BRA. Our findings differ from a recent report concluding
that CDX2 regulates BRA (Savory et al., 2009), but this may
reflect the differing context in which their study was performed
(mouse tail bud). Moreover, our results show that both BRA
and CDX2 regulate not only genes regarded as mesoderm
markers, but also genes previously regarded as trophoblast
markers. While Bra is regarded as a marker of primitive streak,
early mesoderm, node, and notochord, its expression has also
been reported in the allantoic core and in extraembryonic ecto-
derm (Rivera-Pe´rez and Magnuson, 2005; Inman and Downs,
2006). However, there is no known mouse Bra trophoblast
phenotype (Beddington et al., 1992). We thus hypothesized
either that BMP-induced BRA could drive mesodermal expres-
sion of genes traditionally associated with the trophoblast
lineage or that BMP could induce a subpopulation of bona fide
trophoblast, as previously reported (Xu et al., 2002), which reliesCell Stem Cell 9, 144–155, August 5, 2011 ª2011 Elsevier Inc. 151
Figure 5. Cells Expressing HCGa, GCM1, and KRT7 Represent a Subpopulation of Mesoderm Cells
(A) qPCR analysis of KRT7+ and KRT7 cells sorted from hESCs grown as indicated.
(B) Representative fluorescent images of hESCs grown as indicated. Samples were immunostained for KRT7, ISL1, and the nuclear marker DAPI.
(C) Flow cytometry histograms showing FLK1 (upper panels), VCAM-1 (lower panels), and KRT7 coexpression in hESCs grown as indicated.
(D) qPCR analysis of mouse late epiblast explants grown in pluripotency (A, ActivinA, 10 ng/ml; F, FGF2, 20 ng/ml) or differentiation conditions as indicated.
*p% 0.05; +p% 0.01; t test.
(Ei) Representative fluorescent image of human placental mesenchyme plated for a week in serum-containing medium. Samples were immunostained for KRT7
and with DAPI.
(Eii) qPCR analysis of human placental mesenchyme before plating cells to generate outgrowths.
(F) Representative light and fluorescent images of hESCs differentiated as indicated. White arrowheads point to multinucleated cells.
(G) Flow cytometry histograms showing KRT7 expression, class 1HLA epitopes (W6/32 antibody), class I A andBHLA epitopes (Tu155 antibody), and the epitope
detected by 1B10-fibroblast (1B10-Fib) in hESCs grown as indicated. See also Figure S5.
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would distinguish between these possibilities.
Complementary to the recent report of Yu et al. (2011), we find
that BMP-induced hESCs express mesoderm-associated genes
(ISL1, NKX2.5, CD31, LMO2, and CDX2) in the presence of FGF,
whereas they express trophoblast-associated genes (KRT7,
GCM1, and HCGa) only in the absence of FGF. Importantly, we
show that hESC-derived cells induced by BMP to express the
trophoblast-associated gene KRT7 coexpressed mesoderm-
and trophoblast-associated genes in single-cell assays (immu-
nostaining and flowcytometry). TheBMP4mutantmousepheno-
type adds further support to the hypothesis of a mesodermal
identity for BMP-induced hESCs expressing those genes, as it
has severe mesoderm defects but no apparent trophoblast
phenotype (Winnier et al., 1995). Evidence that FGF8 and
FGFR1mutant mice have defects in embryonic but not extraem-
bryonic mesoderm (Sun et al., 1999; Ciruna and Rossant, 2001)
further raises the possibility that BMP-induced, FGF-indepen-
dent gene expression reflects an extraembryonic mesoderm
identity. Indeed, expression of FLK1, VCAM1, and TBX4, which
are mesoderm-associated genes with developmental roles in
mouse extraembryonic mesoderm, was FGF independent and
was observed in KRT7+ sorted cells. Moreover, treatments that
induced the highest levels of trophoblast-associated genes in
hESCs and EpiSCs (BMP alone or BMP + Sb) also induced
expression of mesoderm-associated genes. Importantly, these
mesoderm genes were not expressed in trophoblast subpopula-
tions, which have been recently isolated and transcriptionally
profiled (Apps et al., 2011), thus further showing that the BMP-
induced cells do not phenocopy placental trophoblast cells. On
the other hand, we readily detected expression of KRT7,
GCM1, and HCGa in primary purified human placental mesen-
chyme cultures (i.e., the extraembryonic mesoderm component
of the placenta), indicating that this is not exclusive to placental
trophoblast. However, a definitive assessment of the identity of
KRT7-expressing, BMP-treated hESC-derived cells as either
embryonic or extraembryonic mesoderm is difficult, because of
the shared expression of numerous mesoderm-associated
genes across embryonic and extraembryonic subsets.
The distinction between mesoderm and trophoblast lineages
based solely on marker genes is problematic, as many or most
of the genes used are dual- or multilineage, rather than lineage-
specific, markers. However, we showed that BMP-treated
hESCs differed clearly in their pattern of HLA class I expression
(and in other cell surface features) from either villous or extravil-
lous placental trophoblast. Furthermore, the high levels of ELF5
promoter methylation (even in conditions most favorable to
trophoblast-associated gene expression) argue against hESC
differentiation into cells with a true trophoblast identity (Hem-
berger et al., 2010). Consistent with this, we observed only low
levels of ELF5 expression in BMP-treated hESCs. This is reminis-
cent of the weak, punctate ELF5 expression in human placenta
mesenchymal cells and contrasts with the prominent ELF5 stain-
ing in nuclei of villous cytotrophoblast (Hemberger et al., 2010).
Taken together, these observations lead us to the conclusion
that the BMP-induced phenotype is not bona fide trophoblast
but is instead a subpopulation of mesodermal cells.
Lastly, our findings that EpiSCs and mouse epiblast explants
respond similarly to hESCs when treated with BMP argues thatthis response is not a result of tissue culture adaptation, but
instead represents an innate property of late (pregastrulation)
epiblast and the pluripotent stem cells that share its pluripotent
state (Brons et al., 2007; Tesar et al., 2007). Genetically unmod-
ified mESCs can also be induced to express trophoblast-associ-
ated genes in some conditions (including BMP4 treatment)
(Hayashi et al., 2010; He et al., 2008; Schenke-Layland et al.,
2007). As mESCs only rarely contribute to trophoblast tissues
(Beddington and Robertson, 1989), their in vitro behavior may
indicate that such conditions drive them to another phenotype
than trophoblast. In addition, it has not been excluded that those
conditions enable mESCs to progress to a late-epiblast-like
state, where they would respond similarly to EpiSCs.
In summary, we show here that BMP and FGF cooperate to
induce differentiation of hESCs, EpiSCs, and mouse epiblast
explants into mesoderm and to inhibit their differentiation into
endoderm. Characterization of differentiating cells reveals a
role for CDX2 in human mesoderm development and places
BRA upstream of CDX2 and other genes previously regarded
as markers of the trophoblast lineage. These findings lead us
to question the previous identification of cells induced by BMP
treatment of hESCs as bona fide trophoblast. After extensive
characterization, we conclude that BMP treatment of hESCs
primarily induces a mesodermal phenotype (possibly extraem-
bryonic mesoderm). We cannot exclude the possibility that, as
has been shown for mESCs, genetic modification of hESCs
might enable the generation of trophoblast from hESCs. Like-
wise, it is possible that alternative differentiation protocols
including the addition of epigenetic modifiers could lead to the
generation of trophoblast from hESCs. However, we have no
evidence to support the thesis that hESCs have the capacity to
generate trophoblast simply by addition of BMP to their growth
medium, in either the presence or the absence of FGF2, or
with Activin/Nodal inhibition (Xu et al., 2002; Zhang et al., 2008;
Vallier et al., 2009; Wu et al., 2008; Yu et al., 2011). Instead, we
show that BMP-induced hESCs expressing trophoblast-associ-
ated genes share key features with mesoderm. Accordingly, we
find that the responses of hESCs and mouse pluripotent stem
cells cultured from late epiblast mirror those previously observed
in the intactmammalian embryo. In all, this reinforces the utility of
pluripotent mammalian stem cells as in vitro models for mamma-
lian development.EXPERIMENTAL PROCEDURES
Human ESC and Mouse EpiSC Culture in Chemically Defined
Conditions
Human ESCs (H9 [WiCell, Madison, WI]) and mEpiSCs (129S2-EpiSCs) were
grown in a chemically defined medium (CDM) as previously described (Brons
et al., 2007). For differentiation, cells were grown in CDM containing PVA
instead of BSA and supplemented as described in the figure legends and in
the Supplemental Information. Transfection and selection of knockdown lines
was done as described in the Supplemental Information.Mouse Late Epiblast Layer Dissection and Culture Conditions
Late epiblast layers were dissected from pregastrulation stages (E6.5) of
129S2 mice and cultured as previously described (Brons et al., 2007). All
mouse studies complied fully with the UK Animals (Scientific Procedures)
Act 1986 as implemented by the University of Cambridge. For differentiation
conditions see the Supplemental Information.Cell Stem Cell 9, 144–155, August 5, 2011 ª2011 Elsevier Inc. 153
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Placental tissue was obtained from elective terminations of normal pregnan-
cies between 6 and 12 weeks gestation. Ethical approval for the use of these
tissues was obtained from the Cambridge Local Research Ethics Committee.
Human placental mesenchyme for culture was isolated by negative selection
(for details see the Supplemental Information). Recovered mesenchyme
was plated down in Hams-F12 (Invitrogen) supplemented with 20% FCS
(Invitrogen) and passaged with 0.2% trypsin for up to four passages.
RNA Extraction, cDNA Synthesis, and Amplification of Mouse Late
Epiblast Layer Explant Cultures
Cultured cells were harvested and amplified as described in the Supplemental
Information.
RNA Extraction and Quantitative Polymerase Chain Reaction
Total RNA was extracted using the RNeasy Mini kit (QIAGEN) following manu-
facturer’s instructions. Each sample was treated with RNase-Free DNase
(QIAGEN). Half a microgram of RNA was reverse-transcribed using Super-
script III reverse transcriptase (Invitrogen). Quantitative polymerase chain
reaction (Q-PCR) mixtures were prepared as described (Applied Biosystems,
4385614). Q-PCR reactions were performed in a 7500 Fast ABI instrument
following manufacturer’s instructions and as described in the Supplemental
Information.
Western-Blot Analysis
Whole-cell protein extraction was done by acetone precipitation of the RLT
flow through from the RNeasy columns (QIAGEN) and the extracts’ concentra-
tions were measured using a detergent compatible Bradford based kit
(BioRad). SDS-PAGE gels (Invitrogen) were run using 10 mg of protein and
blotted into nitrocellulose or PVDF membranes using the iBlot (Invitrogen) as
described in the Supplemental Information.
Immunofluorescence
Cells were fixed for 10min at room temperature in 4%paraformaldehyde (PFA)
and immunostained following standard procedures described in the Supple-
mental Information. Fluorescent images were taken using an Olympus IX71
microscope.
Flow Cytometry of Intracellular Proteins
Cell suspensions were fixed and stained using the Cytofix-Cytoperm kit (BD
Biosciences) and following manufacturer’s instructions as described in the
Supplemental Information. Cells were analyzed using a Beckman Coulter
CyAnADP flow cytometer and FlowJo software (Becton Dickinson).
Flow Cytometry of Extracellular Proteins and Flow Sort
Cell suspensions were first incubated with human IgG (Sigma-Aldrich) to block
Fcg receptor-mediated mAb binding and then immunostained as described in
the Supplemental Information. Cells were either sorted using the MoFlo MLS
high-speed cell sorter (BeckmanCoulter) or analyzed using a FACscan flow
cytometer and Cellquest software (Becton Dickinson).
Bisulphite Sequencing
Cells were lysed in Nuclei Lysis Solution and genomic DNA purification was
done using the Wizard Genomic DNA Purification Kit (Promega) and following
the manufacturer’s instructions. One to two micrograms of genomic DNA was
processed for bisulphite conversion using the EpiTect Bisulfite Kit (QIAGEN)
and following themanufacturer’s instructions. Nested and primary PCR details
are in the Supplemental Information. Gel-purified PCR products were cloned
using the pGEM-T Easy Vector System (Promega) and sequenced.
Microarray Analysis
Sample preparation was performed according to manufacturer’s instructions
(Illumina). Labeled extracts were hybridized to whole-genome bead array
assays (HumanWG-6 v3.0 Expression BeadChip) on an Illumina BeadArray
reader. Heatmaps of gene expression were created by importing subsets of
processed microarray data (for details see the Supplemental Information).154 Cell Stem Cell 9, 144–155, August 5, 2011 ª2011 Elsevier Inc.ACCESSION NUMBERS
All microarray data are publicly available in MIAME format from the
ArrayExpress microarray data repository (European Bioinformatics Institute;
E-MTAB-464).SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, Supplemental Experimental
Procedures, and two tables and can be found with this article online at
doi:10.1016/j.stem.2011.06.015.ACKNOWLEDGMENTS
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